← All companies
Hippos
Edge AI Embedded in the Human Body
health AImedtechbiomechanicswearable robotics
StageSeed
Raised$6.2M
Employees5
LocationSan Francisco, CA
About
Hippos is bringing symbiotic intelligence to the human body. We embed edge AI inside soft exoskeletons that continuously sense, predict, and respond to the body's physical signals in real time. Proprietary high-frequency sensing fused with active intervention layers woven into textile, engineered to resist physical failure under extreme stress. We are a team of roboticists, biomechanists, and clinicians building the first AI that lives on the human body, learns from it, and augments it.
Product
- Value proposition
- Embedding edge AI inside soft exoskeletons to sense, predict, and respond to the body's signals in real time, enabling continuous, high-signal biomechanical intelligence and proactive intervention.
- Target customers
- soldiers (military), elite athletes, post-surgical patients
Founders
- David Connors — Co-Founder, former VP of Product Strategy at Workday
- Faaez Ul Haq — Co-Founder, formerly led data functions and ML model builds at Pipe and Data Science team at Uber
Categories
Products
soft exoskeletons with embedded edge AIon-body sensing and intervention layersbiomechanical data platform (in-form, real-time)
Key features
edge AI on the human bodyhigh-frequency sensingactive intervention layers woven into textiledata-driven personalization across tails of movement (extremes)continuous sensing, prediction, and response
Technologies
edge AIsensor fusiontextile-integrated actuation/interventionbiomechanics modelingin-vivo data collection
Target conditions
ACL injuriesknee biomechanicspost-surgical recoverysoft-tissue and joint degradation
Care settings
on-body wearableclinical settingssports and athletic performancemilitary use
Traction metrics
“8 billion human bodies” data source framingACL dataset with n=8 subjects50+ hours of high-intensity biomechanical data across 15 elite athleteslive-subject quantification across 17 athletes and 3 intervention designsintervention reduced peak valgus angle from 6.1° to 1.95°
Investors
RTP GlobalSwift VenturesRackhouse Venture CapitalDifference PartnersFour Acres Capital
News
- Transforming European healthcare: HippocrAItes’ EHDS-ready health data platform | AWS Public Sector Blog · 2025-06-11T13:04:45.000Z
- What is Hippo Health Platform? · 2025-04-14T04:45:00.000Z
- Hippo Health Platform gains official market approval in Finland · 2025-06-23T14:41:45.000Z
- Your health, your data: A personal health account for healthcare · 2025-09-24T13:09:13.000Z
- Hippo Labs Wins HealthTech Company of the Year at the UK Business Tech Awards 2025 - UK Business Tech Awards · 2025-10-01T13:20:07.000Z
- Evaluating efficiency in occupational health care – HippocrAItes and Medics24 launch the OH360 program · 2025-11-06T09:38:20.000Z


